SPONSOR
Myricx Pharma Limited
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced and/or Metastatic Solid Tumors Known to Express B7-H3
Myricx Pharma Limited is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced and/or Metastatic Solid Tumors Known to Express B7-H3.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Myricx Pharma Limited
How many clinical trials has Myricx Pharma Limited sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Myricx Pharma Limited, of which 1 are actively recruiting participants. These trials cover conditions including Advanced and/or Metastatic Solid Tumors Known to Express B7-H3. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Myricx Pharma Limited research focus on?
Myricx Pharma Limited clinical trials span Advanced and/or Metastatic Solid Tumors Known to Express B7-H3. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Myricx Pharma Limited clinical trial?
To participate in a Myricx Pharma Limited trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Myricx Pharma Limited trials with current recruitment status updated daily.
Clinical Trials by Myricx Pharma Limited
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology